US Alzheimer's Disease Market and Competitive Landscape Highlights - 2016

  • ID: 3679719
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Alzheimer's Disease Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Alzheimer's Disease pipeline products, Alzheimer's Disease epidemiology, Alzheimer's Disease market valuations and forecast, Alzheimer's Disease products sales and competitive landscape in the US.

The research is classified into nine sections – Alzheimer's Disease overview including etiology, pathophysiology, and diagnosis, Alzheimer's Disease treatment options, Alzheimer's Disease pipeline products, Alzheimer's Disease market analysis comprising of Alzheimer's Disease epidemiology, key products marketed for Alzheimer's Disease, market valuations and forecast, products sales and market shares.

Research Scope:
- Alzheimer's Disease Pipeline: Find out the products in clinical trials for the treatment of Alzheimer's Disease by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Alzheimer's Disease Epidemiology: Find out the number of patients diagnosed (prevalence) with Alzheimer's Disease in the US
- Alzheimer's Disease Products: Identify key products marketed and prescribed for Alzheimer's Disease in the US, including trade name, molecule name, and company
- Alzheimer's Disease Product Sales: Find out the sales revenues of Alzheimer's Disease products, both branded and generics, in the US
- Alzheimer's Disease Market Valuations: Find out the market size for Alzheimer's Disease products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Alzheimer's Disease Products Market Share: Find out the market shares for key Alzheimer's Disease products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Alzheimer's Disease market analysis and sales trends
- Track competitor drugs sales and market share in the US Alzheimer's Disease market
- Track competitive developments in Alzheimer's Disease market and present key issues and learnings
- Synthesize insights for Alzheimer's Disease market and products to drive business performance
- Answer key business questions about the Alzheimer's Disease market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Alzheimer's Disease products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Alzheimer's Disease Treatments
3) Alzheimer's Disease Pipeline
4) US Alzheimer's Disease Epidemiology
5) Marketed Drugs for Alzheimer's Disease in US
6) US Alzheimer's Disease Market Size
7) US Alzheimer's Disease Products Sales
8) US Alzheimer's Disease Market Competitive Landscape
9) US Alzheimer's Disease Market Forecast
10) Methodology
11) Contact us

1. Alzheimer's Disease Epidemiology, US, 2010 - 2020
2. Alzheimer's Disease Market Size ($), US, 2010 – 2015
3. Alzheimer's Disease Products Market Share (%), US, 2015
4. Alzheimer's Disease Market Forecast ($), US, 2015 – 2020

1. Alzheimer's Disease Phase 3 Clinical Trials, 2016
2. Alzheimer's Disease Phase 2 Clinical Trials, 2016
3. Alzheimer's Disease Phase 1 Clinical Trials, 2016
4. Alzheimer's Disease Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Alzheimer's Disease, US, 2016
6. Alzheimer's Disease Market Size ($), US, 2010 – 2015
7. Alzheimer's Disease Product Sales ($), US, 2010 – 2015
8. Alzheimer's Disease Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll